The comparison is social media shorthand for a real but modest research profile - not a claim of pharmaceutical equivalence
Leach JP, Smith PE, Craig J, Bagary M, Cavanagh D, Duncan S, Kelso AR, Marson AG, McCorry D, Nashef L, Nelson-Piercy C, Northridge R, Sieradzan K, Thangaratinam S, Walker M, Winterbottom J, Reuber M
doi:10.1016/j.bbrc.2020.03.044 127
In June 2026 the MHRA approved oral semaglutide, marketed as the Wegovy pill , the first oral GLP-1 receptor agonist licensed in the UK for weight management (distinct from Rybelsus, a lower-dose oral semaglutide licensed for type 2 diabetes)
Shop Medications , In this blog, we will discuss how rapid weight loss leads to a loss of muscle tissue and ways to prevent it